실시간 바이오 인텔리전스 · ADC · CGT

함께 비교하는 진짜 ADC · Antibody · CGT 데이터

9,268+프로그램
35+FDA 승인
4,079+모집 중
ADC 1068·Antibody 5456·CGT 2744차세대 추천 →·Data Tier →
9268프로그램35FDA 승인
0오늘 방문
572누적 방문
8122갱신 대기S–CData TierS/A/B차세대1068HER2 breast5456Antibody2744CGT→Psoriasis→NSCLC35FDA 승인
피드Data Tier차세대

추천 비교

비교 도구 →
HER2 ADCEnhertu · Kadcyla · RC48CD19 CAR-TYescarta · KymriahPD-1Keytruda · Opdivo다발골수종Darzalex · BlenrepTROP2 ADCTrodelvy · Dato-DXd · SGNectin-4 · TROP2Padcev · Trodelvy건선 IL pathwayStelara · Cosentyx · SkyriziAnti-VEGF (안과)Eylea · LucentisAnti-TNFHumira · EnbrelIL-12/23Stelara · Skyrizi아토피·IL-13Dupixent · Ebglyss혈우병 유전자치료Hemgenix · Roctavian겸상적혈구 CGTCasgevy · Lyfgenia망막·DMD 유전자치료Luxturna · Elevidys

최근 활동

RSS →

빠른 검색 · 이슈 태그

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 4,162개
다음 갱신 D-11 · 마지막 7월 13일
CGTBiologicMedical College of WisconsinPhase 2

12-Day Production of Car-T Cells (12-Day Production of Car-T Cells)

Non Hodgkin Lymphoma (NHL); Mantle Cell Lymphoma (MCL) · Non Hodgkin Lymphoma (NHL)

#NonHodgkinLymphomaNHL#CGT#Phase2#세포유전치료#CAR-T+4
임상시험 2상태 RECRUITING
AntibodystaleJanssenApproved

infliximab, azathioprine (infliximab, azathioprine)

Crohn's Disease · Crohn Disease

#CrohnDisease#Antibody#Approved#항체#면역항체+3
임상시험 2상태 ACTIVE
ADCBiologicstaleNational Cancer Institute (NCI)Phase 1

Brachyury-TRICOM (Brachyury-TRICOM)

Breast Cancer; Triple Negative Breast Cancer · HER2

#HER2#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+3
임상시험 2상태 DISCONTINUED
ADCBiologicstaleShanghai Fudan-Zhangjiang Bio-P…Phase 1

FDA018-ADC (FDA018-ADC)

Advanced/ Metastatic Solid Tumors · Triple Negative Breast Cancer

#TripleNegativeBreastCancer#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+3
임상시험 2상태 RECRUITING
ADCBiologicstaleOncomatryx Biopharma S.L.Phase 1

OMTX705 (OMTX705)

Advanced Solid Tumor · Advanced Solid Tumor

#AdvancedSolidTumor#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+1
임상시험 2상태 RECRUITING
AntibodystaleRocheApproved

Bevacizumab Injection [Avastin] (Bevacizumab Injection [Avastin])

Retinal Neovascularization; Macular Edema · Retinal Neovascularization

#RetinalNeovascularization#Antibody#Approved#항체#면역항체+3
임상시험 2상태 ACTIVE
AntibodystaleGenmabPhase 2

Zalutumumab (Zalutumumab)

Colorectal Cancer · Colorectal Cancer

#ColorectalCancer#Antibody#Phase2#항체#면역항체+2
임상시험 2상태 ACTIVE
AntibodystaleEli LillyPhase 3

Cetuximab, Capecitabine (Cetuximab, Capecitabine)

Colorectal Cancer · Colorectal Cancer

#ColorectalCancer#Antibody#Phase3#항체#면역항체+2
임상시험 2상태 ACTIVE
ADCBiologicstaleShanghai Fudan-Zhangjiang Bio-P…Phase 1

FZ-AD005 (FZ-AD005)

High Grade Glioma (III or IV); Diffuse Midline Glioma (DMG) · High Grade Glioma (III or IV)

#HighGradeGliomaIIIorIV#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+2
임상시험 2상태 RECRUITING
AntibodystaleAbbViePhase 3

adalimumab (Humira, Open-label Adalimumab)

Axial Spondyloarthritis · Axial Spondyloarthritis

#AxialSpondyloarthritis#Antibody#Phase3#항체#면역항체+2
효능 ORR 98.85%임상시험 2상태 ACTIVE
AntibodystaleMerck Sharp & Dohme LLCPhase 2

Robatumumab (Robatumumab)

Colorectal Cancer · Colorectal Cancer

#ColorectalCancer#Antibody#Phase2#항체#면역항체+2
임상시험 2상태 DISCONTINUED
ADCBiologicstaleBristol-Myers SquibbPhase 2

BMS-986148 (BMS-986148)

Advanced Cancer · Advanced Cancer

#AdvancedCancer#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1
효능 ORR 0%임상시험 2상태 DISCONTINUED
AntibodystaleEli LillyPhase 2

Cetuximab + Paclitaxel (Cetuximab + Paclitaxel)

Head and Neck Cancer · Head and Neck Cancer

#HeadandNeckCancer#Antibody#Phase2#항체#면역항체+2
효능 ORR 41.6%임상시험 2상태 DISCONTINUED
AntibodystaleEli LillyPhase 2

cetuximab, cisplatin (cetuximab, cisplatin)

Head and Neck Cancer · Breast Neoplasm

#BreastNeoplasm#Antibody#Phase2#항체#면역항체+3
효능 ORR 73%임상시험 2상태 ACTIVE
ADCBiologicstaleGSKPhase 2

belantamab mafodotin (Blenrep, GSK2857916, Belantamab mafodotin, dexamethasone, ixazomib, pomalidomide)

Relapsed Refractory Multiple Myeloma · FRα

#FR#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2
임상시험 2상태 ACTIVE
ADCBiologicstaleAbbViePhase 1

IMGN151 (IMGN151)

Endometrial Cancer; High Grade Serous Adenocarcinoma of Ovary · Endometrial Cancer

#EndometrialCancer#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+2
임상시험 2상태 RECRUITING
ADCBiologicstaleGSKPhase 2

belantamab mafodotin (Blenrep, GSK2857916, Belantamab mafodotin frozen liquid)

Multiple Myeloma · Multiple Myeloma

#MultipleMyeloma#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1
효능 ORR 34%임상시험 2상태 ACTIVE
AntibodystaleMerck Sharp & Dohme LLCPhase 2

Dalotuzumab (Dalotuzumab)

Rectal Neoplasms · Rectal Neoplasms

#RectalNeoplasms#Antibody#Phase2#항체#면역항체+2
효능 ORR 21.6%임상시험 2상태 ACTIVE
ADCBiologicstaleFudan UniversityPhase 2

TQB2102 with TQB2868 (TQB2102 with TQB2868)

Triple-negative Breast Cancer · Triple-negative Breast Cancer

#Triple-negativeBreastCancer#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1
임상시험 2상태 RECRUITING
ADCBiologicPyxis Oncology, IncthroughPhase 2

PYX-201 (PYX-201)

Advanced Solid Tumors · Solid Tumor

#SolidTumor#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+4
임상시험 2상태 RECRUITING
ADCBiologicstaleGlaxoSmithKlinePhase 3

GSK5733584 (GSK5733584)

Neoplasms, Endometrial · Neoplasms, Endometrial

#NeoplasmsEndometrial#ADC#Phase3#항체약물접합체#antibody-drug-conjugate+3
임상시험 2상태 RECRUITING
AntibodystaleEli Lilly and CompanyPhase 2

cixutumumab (IMC-A12, IMC-A12 (cixutumumab))

Non-Small Cell Lung Cancer · Colon Cancer

#ColonCancer#Antibody#Phase2#항체#면역항체+3
효능 ORR 37.9%임상시험 2상태 ACTIVE
AntibodystaleTakedaPhase 2

Mezagitamab (Mezagitamab)

Relapsed and/or Refractory Multiple Myeloma (RRMM) · FRα

#FR#Antibody#Phase2#항체#면역항체+4
효능 ORR 25%임상시험 2상태 ACTIVE
AntibodystaleJanssenPhase 1

daratumumab (Darzalex, Actinium Ac 225-DOTA-Daratumumab)

Acute Lymphoblastic Leukemia; Acute Myeloid Leukemia · FRα

#FR#Antibody#Phase1#항체#면역항체+4
임상시험 2상태 RECRUITING
AntibodystaleJanssenPhase 2

daratumumab (Darzalex, 89Zr-DFO-daratumumab)

Multiple Myeloma · Multiple Myeloma

#MultipleMyeloma#Antibody#Phase2#항체#면역항체+2
임상시험 2상태 DISCONTINUED

52 / 167 페이지

← 이전다음 →
전체 9,268개 프로그램 보기